Article
The WHO and FDA are at odds over remdesivir
Rating:
0.0
Views:
164
Likes:
1
Library:
1
Last week, COVID-19 cases throughout the US continued to rise, AstraZeneca announced their potential vaccine did well in clinical trials, studies showed the adverse effects of infection on the heart, and the WHO advised against using remdesivir as a treatment in the days leading up to Thanksgiving.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value